Clinical Trial Update: Sargramostim for Myeloid Dendritic Cell Deficiency [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating sargramostim for dendritic cell deficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dendritic Cell Deficiency

Drugs mentioned

• Leukine (sargramostim)

Snippet

Sponsor: Johns Hopkins University | Conditions: Dendritic Cell Deficiency | Phase 1 | Status: COMPLETED